Clarke Neumann - 15 Feb 2023 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role
Senior Vice President, General Counsel and Secretary
Signature
/s/ Will Pridgen, Attorney-in-Fact for Clarke Neumann
Issuer symbol
BIORQ
Transactions as of
15 Feb 2023
Net transactions value
-$291
Form type
4
Filing time
17 Feb 2023, 15:15:32 UTC
Previous filing
05 Jan 2023
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Tax liability $291 -84 -0.39% $3.46 21,618 15 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 150 vested restricted stock units on February 15, 2023.

Remarks:

Senior Vice President, General Counsel and Secretary